Hepatotoxicity after high‐dose intravenous methylprednisolone in multiple sclerosis patients
Key Clinical Message Hepatotoxicity is a rare adverse event of methylprednisolone that should be considered in clinical practice. In patients at risk, we propose liver function surveillance, by measuring hepatic enzymes concentration 15–30 days after methylprednisolone administration. Additionally,...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley
2017-08-01
|
| Serie: | Clinical Case Reports |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1002/ccr3.1033 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|